Imaging Center

As novel therapeutics, focused on repair and neuroprotection, are developed in multiple sclerosis (MS), the need for accurate markers to measure the disease is essential to translate these agents from the lab to clinical trials in patients with MS. Our imaging program is a novel multi-modality program for MS, which includes both MRI and positron emission tomography (PET). We are focusing our efforts on developing new methods to measure the ongoing damage which is occurring to the myelin and nerves in patients with MS.

Our imaging research program, led by Dr. Susan Gauthier, is a collaborative effort between the Weill Cornell Medical College departments of Neurology (MS center and laboratory), Radiology and Nuclear Medicine. Dr. Ashish Raj leads a team of doctorate level computer scientists at the Imaging Data Evaluation and Analytics Lab (IDEAL); members of his team work closely with a physicist, Dr. Thanh Nguyen, and Dr. Gauthier to create new approaches for the use of MRI to monitor disease progression in MS. The PET aspect of our program is a collaborative effort with Dr. Shankar Vallabhajosula, Professor of Radiochemistry and Radiopharmacy in the department of Radiology. Dr. Vallabhajosula is a senior investigator in molecular imaging at Weill Cornell Medical College and the Director of Research in Nuclear medicine and PET at the Citigroup Biomedical Imaging Center (CBIC). Members of the MRI and PET teams work together to understand how both methods can be used together to improve our ability to measure that damage that occurs to myelin and nerves in MS. Lastly, translation of laboratory discoveries can be facilitated through our animal imaging program, which includes both investigators from the imaging team as well as from Dr. Vartanian’s laboratory.

Back to Top